NDC 0019-0862-07 - Cysto-Conray II
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0019-0862
- Requested NDC
- 0019-0862-07
- Package NDCs from labels
- 0019-0862-50, 0019-0862-07
- Manufacturer
- Liebel-Flarsheim Company LLC | Justesa Imagen, S.A.U.
- Effective date
- 2020-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cysto-Conray II - Liebel-Flarsheim Company LLC | Justesa Imagen, S.A.U. | Liebel-Flarsheim Company LLC | Justesa Imagen, S.A.U. | 2020-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0019-0862-50 | Cysto-Conray II | 250 mL in 1 BOTTLE, GLASS | INJECTION | 250 | 18 | |
| 0019-0862-50 | Cysto-Conray II | 12 in 1 BOX | INJECTION | 12 | 18 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0019-0862-07 | ML - Milliliter | 0019-0862 | 6d477efb-0ccb-4951-a478-c18eb25dfab6 | 1 | 2013-02-13 |
| 0019-0862-09 | ML - Milliliter | 0019-0862 | fd277ead-e13b-4f24-b37f-67380ca151e9 | 1 | 2013-02-11 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| IOTHALAMATE MEGLUMINE | ACTIVE INGREDIENT | XUW72GOP7W | CYSTO-CONRAY II (IOTHALAMATE MEGLUMINE) INJECTION [MALLINCKRODT INC.] | 13 | |
| IOTHALAMIC ACID | ACTIVE MOIETY | 16CHD79MIX | CYSTO-CONRAY II (IOTHALAMATE MEGLUMINE) INJECTION [MALLINCKRODT INC.] | 13 | |
| EDETATE CALCIUM DISODIUM | INACTIVE INGREDIENT | 25IH6R4SGF | CYSTO-CONRAY II (IOTHALAMATE MEGLUMINE) INJECTION [MALLINCKRODT INC.] | 13 | |
| SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | INACTIVE INGREDIENT | 3980JIH2SW | CYSTO-CONRAY II (IOTHALAMATE MEGLUMINE) INJECTION [MALLINCKRODT INC.] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fleet | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | C.B. Fleet Company, Inc. | f50ba829-16c3-40a7-9822-8d6d00353b33 | 2024-02-29 | Warnings | 3980JIH2SW |
| Cysto-Conray II | IOTHALAMATE MEGLUMINE | Liebel-Flarsheim Company LLC | 8841ab4d-674d-4beb-88a5-13e35f6005cc | 2020-12-31 | Boxed warning, Warnings, Adverse reactions | NDA017057 0019-0862-50 0019-0862 ff628e06-2cb5-4714-a741-1dec04bd5602 8841ab4d-674d-4beb-88a5-13e35f6005cc XUW72GOP7W |
| FREDS SALINE TWIN PACK LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | FRED'S | 7d15057f-eb3b-477f-ab14-68c3c38ea910 | 2018-12-26 | Warnings | 3980JIH2SW |
| Marcs Twin Pack | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Marc Glassman Inc. | 66348ee5-803a-4b78-94dd-55bc9d3543c3 | 2018-07-10 | Warnings | 3980JIH2SW |
| QUALITY CHOICE SINGLE SALINE LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Alcyon Health, LLC. | eb499c7f-9c7b-4097-83a3-82aabffd6beb | 2017-07-12 | Warnings | 3980JIH2SW |
| Pro-Enema Single Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Propharma Medical Supplies | e53c5eda-21da-4aed-a592-315100167cc2 | 2017-06-08 | Warnings | 3980JIH2SW |
| Saline Laxative Cherry Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Dolgencorp Inc. | ca3c00d9-4301-4de8-94f5-34f1bcc761ab | 2017-04-13 | Warnings | 3980JIH2SW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.